TTM Technologies stock jumps as Raytheon’s $200 million deal and S&P MidCap 400 move stir buying
30 January 2026
1 min read

TTM Technologies stock jumps as Raytheon’s $200 million deal and S&P MidCap 400 move stir buying

New York, January 30, 2026, 14:04 EST — Regular session

  • TTMI climbed 3.7% in afternoon trading, bouncing between $95.06 and $103.36 earlier in the session
  • Company revealed a multi-year supply agreement with Raytheon, valued at up to $200 million
  • Investors are focused on the Feb. 4 results and the company’s 2026 outlook

TTM Technologies shares rose 3.7% to $100.03 Friday afternoon, bouncing back after an initial drop as investors reacted to new defense-contract news and picked up shares linked to index activity. The stock swung between $95.06 and $103.36, with roughly 1.8 million shares changing hands.

Timing is crucial. A multi-year defense contract provides suppliers steady work and clearer planning over extended programs. Shifts in the index can also trigger automatic buying, no matter what anyone thinks about the valuation.

The stock slips into a packed field of hardware and defense names, where any sign of slowing orders gets punished fast. With TTM’s quarterly update coming next week, traders see Friday’s rally more as a prelude than a finish line.

Late Wednesday, Costa Mesa-based TTM Technologies announced that Raytheon, part of RTX, secured a multi-year contract for radio frequency assemblies, electronic hardware, and printed circuit boards tied to the Lower Tier Air and Missile Defense Sensor radar program. The deal could be worth up to $200 million across three years. Mike Mills highlighted that the agreement supports “our accelerated delivery schedule while reducing costs.” Catherine Gridley of TTM described the move as one that “reinforces our long-standing partnership with Raytheon.” 1

Aside from the contract win, S&P Dow Jones Indices announced that TTM has been added to the S&P MidCap 400, effective before Friday’s open, moving out of the S&P SmallCap 600. 2

Index reshuffling like this often sparks quick, intense moves as passive funds realign their holdings. But these bursts usually subside fast, with the stock settling back into trading based on fundamentals.

Defense primes showed a mixed performance on Friday. RTX held steady, Lockheed Martin gained roughly 1%, and Northrop Grumman dropped close to 1.3%.

TTM is set to report its fourth-quarter 2025 earnings on Feb. 4, holding a conference call at 4:30 p.m. EST. The results will be released after the market closes. 3

However, the rally carries a distinct risk. That $200 million number is only “potential” value, with progress tied to program timelines and client demand; margins can shift even if revenue appears steady. A cautious note on Feb. 4 — or any hint of weakening orders — might reverse some of the gains from index moves and contracts.

Traders are focused on whether Friday’s gains stick through the close and carry over into next week’s positioning. The next major event is Feb. 4, when management will report results and provide guidance.

Stock Market Today

Disney stock ends week higher after Friday bounce — what to watch for DIS next week

Disney stock ends week higher after Friday bounce — what to watch for DIS next week

7 February 2026
Disney shares closed up 3.6% at $108.70 Friday, recovering from earlier losses as U.S. stocks rallied and the Dow topped 50,000. Investors are watching Super Bowl streaming economics and Disney’s CEO transition, with Josh D’Amaro set to take over at the March 18 meeting. Disney reported quarterly revenue of $25.98 billion and adjusted EPS of $1.63, while segment operating income fell 9% to $4.6 billion.
Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

7 February 2026
Novo Nordisk Class B shares closed up 5.3% at 295.50 Danish crowns in Copenhagen after Hims & Hers said it would stop offering a compounded pill version of Wegovy following U.S. regulatory warnings. The move came after Novo called the Hims product “illegal mass compounding” and threatened legal action. Shares had fallen nearly 8% Thursday after Hims launched the pill. Trading resumes Monday.
Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

7 February 2026
Linde plc shares fell 2.5% to $448.24 Friday after reporting Q4 sales up 6% to $8.76 billion and adjusted EPS of $4.20. The company guided 2026 adjusted EPS to $17.40–$17.90, below analyst consensus. JPMorgan downgraded the stock, while Morgan Stanley and UBS raised price targets. Linde repurchased $1.4 billion in shares in Q4 and returned $7.4 billion to shareholders in 2025.
AT&T stock price jumps nearly 4% as Verizon Communications buyback jolts telecom shares
Previous Story

AT&T stock price jumps nearly 4% as Verizon Communications buyback jolts telecom shares

Cisco stock price today: CSCO slips as Wall Street frets rates and Cisco pushes new AI security tools
Next Story

Cisco stock price today: CSCO slips as Wall Street frets rates and Cisco pushes new AI security tools

Go toTop